Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-16 12:54 pm Purchase | 13G | ITEOS THERAPEUTICS INC. ITOS | EcoR1 Capital LLC | 1,944,672 5.4% | 1,944,672 (New Position) | View |
2024-02-14 09:45 am Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,259,476 3.5% | -551,359 (-30.45%) | View |
2024-02-13 5:08 pm Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | VANGUARD GROUP INC | 1,490,942 4.17% | -328,088 (-18.04%) | View |
2024-01-23 4:13 pm Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | BlackRock Inc. BLK | 4,261,745 11.9% | -217,676 (-4.86%) | View |
2024-01-09 4:26 pm Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | MILLENNIUM MANAGEMENT LLC | 967,402 2.7% | -1,123,431 (-53.73%) | View |
2023-10-24 4:12 pm Purchase | 13G | ITEOS THERAPEUTICS INC. ITOS | MILLENNIUM MANAGEMENT LLC | 2,090,833 5.8% | 2,090,833 (New Position) | View |
2023-02-14 10:08 am Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | RTW INVESTMENTS LP | 0 0% | -2,353,015 (Position Closed) | View |
2023-02-13 6:14 pm Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,810,835 5.1% | -118,366 (-6.14%) | View |
2023-02-09 11:22 am Purchase | 13G | ITEOS THERAPEUTICS INC. ITOS | VANGUARD GROUP INC | 1,819,030 5.11% | 1,819,030 (New Position) | View |
2023-01-26 08:52 am Unchanged | 13G | ITEOS THERAPEUTICS INC. ITOS | BlackRock Inc. BLK | 4,479,421 12.6% | 0 (Unchanged) | View |
2023-01-20 5:17 pm Purchase | 13G | ITEOS THERAPEUTICS INC. ITOS | BlackRock Inc. BLK | 4,479,421 12.6% | 758,184 (+20.37%) | View |
2022-07-08 4:56 pm Purchase | 13G | ITEOS THERAPEUTICS INC. ITOS | BlackRock Inc. BLK | 3,721,237 10.5% | 3,721,237 (New Position) | View |
2022-05-11 5:14 pm Sale | 13D | ITEOS THERAPEUTICS INC. ITOS | Boxer Capital LLC | 2,154,058 6.1% | -988,000 (-31.44%) | View |
2022-05-02 5:02 pm Purchase | 13G | ITEOS THERAPEUTICS INC. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,929,201 5.4% | 1,929,201 (New Position) | View |
2022-03-18 9:00 pm Sale | 13D | ITEOS THERAPEUTICS INC. ITOS | Boxer Capital LLC | 3,142,058 8.9% | -575,201 (-15.47%) | View |
2022-02-14 08:41 am Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | RTW INVESTMENTS LP | 2,353,015 6.7% | -409,776 (-14.83%) | View |
2022-02-10 12:09 pm Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | JANUS HENDERSON GROUP PLC JHG | 3,533 0% | -1,984,597 (-99.82%) | View |
2022-01-05 9:26 pm Sale | 13D | ITEOS THERAPEUTICS INC. ITOS | Boxer Capital LLC | 3,717,259 10.54% | -627,757 (-14.45%) | View |
2021-12-09 8:23 pm Sale | 13D | ITEOS THERAPEUTICS INC. ITOS | MPM BioVentures 2014 L.P. | 4,730,197 13.4% | -407,017 (-7.92%) | View |
2021-10-19 4:06 pm Sale | 13D | ITEOS THERAPEUTICS INC. ITOS | MPM BioVentures 2014 L.P. | 5,137,214 14.6% | -438,998 (-7.87%) | View |